BioSpace News Archive

PacBio announced financial results for the quarter ended March 31, 2022.

Opus Genetics announced promising new preclinical data from studies evaluating the potential of its gene therapies OPGx-001 and OPGx-002 to address forms of Leber congenital amaurosis, a group of rare inherited retinal diseases characterized by photoreceptor degeneration, due to mutations of LCA5 or RDH12 genes, respectively.

Evofem Biosciences, Inc., reported financial results for the three-month period ended March 31, 2022.

Paradigm Biopharmaceuticals Ltd (ASX: PAR) (“Paradigm” or “the Company”), is pleased to report that the first subjects have been randomized and dosed in the United States (U.S.) in the PARA_OA_002 pivotal clinical trial, evaluating injectable pentosan polysulfate sodium (PPS/Zilosul®) for the treatment of pain associated with knee osteoarthritis (kOA).

BioSystics, Inc. , a recent spin-off from the University of Pittsburgh (UPitt), has been developing the Microphysiology Systems Database, the core of the BioSystics Analytics Platform (BioSystics-AP™), with funding over the last ten years from the National Center for Advancing Translational Sciences (NCATS).

Labcorp, a leading global life sciences company, announced that its Annual Meeting of Shareholders will be webcast live beginning May 11, at 9:00 a.m. ET.

The National Academy of Sciences has elected The Feinstein Institutes for Medical Research’s Betty Diamond, MD, in recognition of her breakthrough achievements in molecular medicine and original research.

Amend Surgical, Inc. announced that it has finalized a funding agreement with the Institute for Commercialization of Florida Technology along with being awarded a substantial product development funding from The Michigan-Pittsburgh-Wyss Regenerative Medicine Resource Center.

Rhino Biotech Limited, a Biotech Company, announced it will be presenting at the SNN Network Planet MicroCap Showcase on May 4, 2022 at 2:30 p.m. Pacific Time.

Onconova Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on discovering and developing novel products for patients with cancer, announced that the Company intends to release its first quarter 2022 financial results on Wednesday, May 11, 2022.